title: [Extensive thromboembolism after cardioversion in a patient treated with dabigatran].
abstract: A 65-year-old man, who had been treated with dabigatran for 66 days prior to electrical cardioversion, developed extensive intestinal, renal and cerebral thromboembolism five days after cardioversion. There is limited information available on the treatment of thromboembolism in patients being treated with dabigatran. Routine biochemical monitoring is not available. As is the case for vitamin K antagonists, anticoagulation with dabigatran is not without risks.
authors: Medicinsk Afdeling, Køge Sygehus, Lykkebækvej 1, 4600 Køge, Denmark. torbenbuch@gmail.com
authors: Torben Nicolai
authors: TN
authors: Buch
authors: Jakob
authors: J
authors: Holm
authors: Lars Kristian
authors: LK
authors: Munck
mesh_terms: D000368:Aged; D000991:Antithrombins / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D001562:Benzimidazoles / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002544:Cerebral Infarction / Q000139:chemically induced; D000069604:Dabigatran; D004554:Electric Countershock; D006801:Humans; D045823:Ileus / Q000139:chemically induced; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D012307:Risk Factors; D013923:Thromboembolism / Q000139:chemically induced*; D014057:Tomography, X-Ray Computed; D014812:Vitamin K / Q000037:antagonists & inhibitors; D015091:beta-Alanine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000991:Antithrombins; D001562:Benzimidazoles; D015091:beta-Alanine; D014812:Vitamin K; D000069604:Dabigatran